CARR EDWARD

DNTH

CARR EDWARD serves as officer: CHIEF ACCOUNTING OFFICER at Dianthus Therapeutics, Inc. (DNTH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$3.69M

Net Position

Net Seller

$3.69M

Companies Traded

DNTH, ABEO

Active Period

Mar 2021 – Mar 2026

3 total trades

Most Recent

Sell DNTH

Mar 13, 2026 · $3.56M

CARR EDWARD's Insider Trading at Dianthus Therapeutics, Inc. (DNTH)

Buys

0 · $0.00

Sells

1 · $3.56M

Total Shares Bought

Total Shares Sold

43,682

DNTH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 13, 2026	Sell	43,682	$81.49	$3.56M	27,830

CARR EDWARD's Insider Trading at Abeona Therapeutics Inc. (ABEO)

Buys

0 · $0.00

Sells

2 · $131.3K

Total Shares Bought

Total Shares Sold

84,567

ABEO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 8, 2021	Sell	29,122	$1.05	$30.6K	0
Mar 31, 2021	Sell	55,445	$1.82	$100.7K	0

Related Insiders

Simrat Randhawa

officer: EVP, Head of R&D

DNTHSell · Sep 3, 2026

Mark Alvino

Director

ABEOSell · Sep 1, 2026

Simon Read

director

DNTHSell · Aug 19, 2026

Anne McGeorge

director

DNTHSell · Aug 11, 2026

Adam M Veness

officer: SVP, General Counsel and Sec.

DNTHSell · Aug 11, 2026

Marino Garcia

director, officer: CEO AND PRESIDENT

DNTHSell · Aug 7, 2026

Joseph Walter Vazzano

officer: Chief Financial Officer

ABEOSell · Jul 22, 2026

Ryan Savitz

officer: EVP, CFO & CBO

DNTHSell · Jul 13, 2026

Explore More Insider Trading Data

DNTH Insider Trading Activity

View all insider trades at Dianthus Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity